@comment { BIBTEX_AUTO - GS }
@article{pmid:28129109,
  title={Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization.},
  author={Wang, Wenzhang and Arakawa, Hiroyuki and Wang, Luwen and Okolo, Ogoegbunam and Siedlak, Sandra L and Jiang, Yinfei and Gao, Ju and Xie, Fei and Petersen, Robert B and Wang, Xinglong},
  journal={Molecular therapy : the journal of the American Society of Gene Therapy},
  journal-iso={Mol. Ther.},
  volume={25},
  number={1},
  year={2017},
  month={01},
  pages={127--139},
  doi={10.1016/j.ymthe.2016.10.013},
  pmid={28129109},
  abstract={Dominant missense mutations in TAR DNA-binding protein 43 (TDP-43) cause amyotrophic lateral sclerosis (ALS), and the cytoplasmic accumulation of TDP-43 represents a pathological hallmark in ALS and frontotemporal lobar degeneration (FTD). Behavioral investigation of the transgenic mouse model expressing the disease-causing human TDP-43 M337V mutant (TDP-43M337V mice) is encumbered by premature death in homozygous transgenic mice and a reported lack of phenotype assessed by tail elevation and footprint in hemizygous transgenic mice. Here, using a battery of motor-coordinative and cognitive tests, we report robust motor-coordinative and cognitive deficits in hemizygous TDP-43M337V mice by 8 months of age. After 12 months of age, cortical neurons are significantly affected by the mild expression of mutant TDP-43, characterized by cytoplasmic TDP-43 mislocalization, mitochondrial dysfunction, and neuronal loss. Compared with age-matched non-transgenic mice, TDP-43M337V mice demonstrate a similar expression of total TDP-43 but higher levels of TDP-43 in mitochondria. Interestingly, a TDP-43 mitochondrial localization inhibitory peptide abolishes cytoplasmic TDP-43 accumulation, restores mitochondrial function, prevents neuronal loss, and alleviates motor-coordinative and cognitive deficits in adult hemizygous TDP-43M337V mice. Thus, this study suggests hemizygous TDP-43M337V mice as a useful animal model to study TDP-43 toxicity and further consolidates mitochondrial TDP-43 as a novel therapeutic target for TDP-43-linked neurodegenerative diseases.Published by Elsevier Inc.}
}


% BEGIN:Original PubMed XML
%  <PubmedArticle>
%    <MedlineCitation Status="MEDLINE" Owner="NLM">
%      <PMID Version="1">28129109</PMID>
%      <DateCompleted>
%        <Year>2017</Year>
%        <Month>06</Month>
%        <Day>06</Day>
%      </DateCompleted>
%      <DateRevised>
%        <Year>2018</Year>
%        <Month>02</Month>
%        <Day>26</Day>
%      </DateRevised>
%      <Article PubModel="Print-Electronic">
%        <Journal>
%          <ISSN IssnType="Electronic">1525-0024</ISSN>
%          <JournalIssue CitedMedium="Internet">
%            <Volume>25</Volume>
%            <Issue>1</Issue>
%            <PubDate>
%              <Year>2017</Year>
%              <Month>01</Month>
%              <Day>04</Day>
%            </PubDate>
%          </JournalIssue>
%          <Title>Molecular therapy : the journal of the American Society of Gene Therapy</Title>
%          <ISOAbbreviation>Mol. Ther.</ISOAbbreviation>
%        </Journal>
%        <ArticleTitle>Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization.</ArticleTitle>
%        <Pagination>
%          <MedlinePgn>127-139</MedlinePgn>
%        </Pagination>
%        <ELocationID EIdType="pii" ValidYN="Y">S1525-0016(16)45368-2</ELocationID>
%        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ymthe.2016.10.013</ELocationID>
%        <Abstract>
%          <AbstractText>Dominant missense mutations in TAR DNA-binding protein 43 (TDP-43) cause amyotrophic lateral sclerosis (ALS), and the cytoplasmic accumulation of TDP-43 represents a pathological hallmark in ALS and frontotemporal lobar degeneration (FTD). Behavioral investigation of the transgenic mouse model expressing the disease-causing human TDP-43 M337V mutant (TDP-43<sup>M337V</sup> mice) is encumbered by premature death in homozygous transgenic mice and a reported lack of phenotype assessed by tail elevation and footprint in hemizygous transgenic mice. Here, using a battery of motor-coordinative and cognitive tests, we report robust motor-coordinative and cognitive deficits in hemizygous TDP-43<sup>M337V</sup> mice by 8 months of age. After 12 months of age, cortical neurons are significantly affected by the mild expression of mutant TDP-43, characterized by cytoplasmic TDP-43 mislocalization, mitochondrial dysfunction, and neuronal loss. Compared with age-matched non-transgenic mice, TDP-43<sup>M337V</sup> mice demonstrate a similar expression of total TDP-43 but higher levels of TDP-43 in mitochondria. Interestingly, a TDP-43 mitochondrial localization inhibitory peptide abolishes cytoplasmic TDP-43 accumulation, restores mitochondrial function, prevents neuronal loss, and alleviates motor-coordinative and cognitive deficits in adult hemizygous TDP-43<sup>M337V</sup> mice. Thus, this study suggests hemizygous TDP-43<sup>M337V</sup> mice as a useful animal model to study TDP-43 toxicity and further consolidates mitochondrial TDP-43 as a novel therapeutic target for TDP-43-linked neurodegenerative diseases.</AbstractText>
%          <CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation>
%        </Abstract>
%        <AuthorList CompleteYN="Y">
%          <Author ValidYN="Y">
%            <LastName>Wang</LastName>
%            <ForeName>Wenzhang</ForeName>
%            <Initials>W</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Arakawa</LastName>
%            <ForeName>Hiroyuki</ForeName>
%            <Initials>H</Initials>
%            <AffiliationInfo>
%              <Affiliation>Rodent Behavioral Core, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Wang</LastName>
%            <ForeName>Luwen</ForeName>
%            <Initials>L</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Okolo</LastName>
%            <ForeName>Ogoegbunam</ForeName>
%            <Initials>O</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Siedlak</LastName>
%            <ForeName>Sandra L</ForeName>
%            <Initials>SL</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Jiang</LastName>
%            <ForeName>Yinfei</ForeName>
%            <Initials>Y</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Gao</LastName>
%            <ForeName>Ju</ForeName>
%            <Initials>J</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Xie</LastName>
%            <ForeName>Fei</ForeName>
%            <Initials>F</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Petersen</LastName>
%            <ForeName>Robert B</ForeName>
%            <Initials>RB</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%          <Author ValidYN="Y">
%            <LastName>Wang</LastName>
%            <ForeName>Xinglong</ForeName>
%            <Initials>X</Initials>
%            <AffiliationInfo>
%              <Affiliation>Department of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH 44106, USA. Electronic address: xinglong.wang@case.edu.</Affiliation>
%            </AffiliationInfo>
%          </Author>
%        </AuthorList>
%        <Language>eng</Language>
%        <GrantList CompleteYN="Y">
%          <Grant>
%            <GrantID>R01 NS089604</GrantID>
%            <Acronym>NS</Acronym>
%            <Agency>NINDS NIH HHS</Agency>
%            <Country>United States</Country>
%          </Grant>
%        </GrantList>
%        <PublicationTypeList>
%          <PublicationType UI="D016428">Journal Article</PublicationType>
%          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
%        </PublicationTypeList>
%        <ArticleDate DateType="Electronic">
%          <Year>2017</Year>
%          <Month>01</Month>
%          <Day>04</Day>
%        </ArticleDate>
%      </Article>
%      <MedlineJournalInfo>
%        <Country>United States</Country>
%        <MedlineTA>Mol Ther</MedlineTA>
%        <NlmUniqueID>100890581</NlmUniqueID>
%        <ISSNLinking>1525-0016</ISSNLinking>
%      </MedlineJournalInfo>
%      <ChemicalList>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>
%        </Chemical>
%        <Chemical>
%          <RegistryNumber>0</RegistryNumber>
%          <NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance>
%        </Chemical>
%      </ChemicalList>
%      <CitationSubset>IM</CitationSubset>
%      <CommentsCorrectionsList>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Exp Med. 2010 Aug 2;207 (8):1661-73</RefSource>
%          <PMID Version="1">20660618</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2016 Jan 8;351(6269):173-6</RefSource>
%          <PMID Version="1">26634439</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Cell. 2008 Dec 26;135(7):1161-3</RefSource>
%          <PMID Version="1">19109884</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Neurosci. 2010 Jan 13;30(2):639-49</RefSource>
%          <PMID Version="1">20071528</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Neurogenetics. 2010 May;11(2):217-25</RefSource>
%          <PMID Version="1">19760257</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Ann Neurol. 2007 May;61(5):435-45</RefSource>
%          <PMID Version="1">17469117</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Neurosci Methods. 2010 Jun 15;189(2):180-5</RefSource>
%          <PMID Version="1">20359499</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3858-63</RefSource>
%          <PMID Version="1">20133711</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Clin Invest. 2011 Feb;121(2):726-38</RefSource>
%          <PMID Version="1">21206091</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Trends Biochem Sci. 2012 Jun;37(6):237-47</RefSource>
%          <PMID Version="1">22534659</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Front Aging Neurosci. 2015 May 26;7:100</RefSource>
%          <PMID Version="1">26074815</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4309-14</RefSource>
%          <PMID Version="1">24591609</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Neurodegener Dis. 2010;7(4):260-4</RefSource>
%          <PMID Version="1">20197650</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Transl Neurodegener. 2015 Jul 29;4:14</RefSource>
%          <PMID Version="1">26225210</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Science. 2008 Mar 21;319(5870):1668-72</RefSource>
%          <PMID Version="1">18309045</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18809-14</RefSource>
%          <PMID Version="1">19833869</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Biol Chem. 2015 Jan 2;290(1):168-82</RefSource>
%          <PMID Version="1">25416777</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Annu Rev Physiol. 1998;60:619-42</RefSource>
%          <PMID Version="1">9558479</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16325-30</RefSource>
%          <PMID Version="1">20736350</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>PLoS Genet. 2010 Mar 26;6(3):e1000887</RefSource>
%          <PMID Version="1">20361056</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Curr Opin Struct Biol. 2008 Jun;18(3):290-8</RefSource>
%          <PMID Version="1">18515081</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Brain. 2011 Sep;134(Pt 9):2610-26</RefSource>
%          <PMID Version="1">21752789</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Virol. 1995 Jun;69(6):3584-96</RefSource>
%          <PMID Version="1">7745706</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Neurosci. 2010 Aug 11;30(32):10851-9</RefSource>
%          <PMID Version="1">20702714</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Rev Neurosci. 2011 Nov 30;13(1):38-50</RefSource>
%          <PMID Version="1">22127299</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Mol Neurodegener. 2011 Oct 26;6:73</RefSource>
%          <PMID Version="1">22029574</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Med. 2016 Aug;22(8):869-78</RefSource>
%          <PMID Version="1">27348499</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Med. 2016 Jan;22(1):54-63</RefSource>
%          <PMID Version="1">26618722</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):E736-45</RefSource>
%          <PMID Version="1">23382207</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Front Biosci. 2008 Jan 01;13:867-78</RefSource>
%          <PMID Version="1">17981595</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Hum Mutat. 2009 Nov;30(11):E974-83</RefSource>
%          <PMID Version="1">19655382</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Rev Neurosci. 2009 Jul;10(7):519-29</RefSource>
%          <PMID Version="1">19513088</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Neurobiol Dis. 2010 Nov;40(2):404-14</RefSource>
%          <PMID Version="1">20621187</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Curr Protoc Neurosci. 2001 Aug;Chapter 8:Unit 8.12</RefSource>
%          <PMID Version="1">18428540</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Acta Neuropathol. 2009 Sep;118(3):359-69</RefSource>
%          <PMID Version="1">19330339</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>PLoS Genet. 2008 Sep 19;4(9):e1000193</RefSource>
%          <PMID Version="1">18802454</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>Nat Genet. 2008 May;40(5):572-4</RefSource>
%          <PMID Version="1">18372902</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="Cites">
%          <RefSource>J Neurochem. 2009 May;109(4):1179-91</RefSource>
%          <PMID Version="1">19519782</PMID>
%        </CommentsCorrections>
%        <CommentsCorrections RefType="CommentIn">
%          <RefSource>Mol Ther. 2017 Jan 4;25(1):10-11</RefSource>
%          <PMID Version="1">28129105</PMID>
%        </CommentsCorrections>
%      </CommentsCorrectionsList>
%      <MeshHeadingList>
%        <MeshHeading>
%          <DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName>
%          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
%          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
%          <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
%          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
%          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName>
%          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
%          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
%          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
%          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D008124" MajorTopicYN="N">Locomotion</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName>
%          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
%          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D053580" MajorTopicYN="N">Muscle Strength</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
%          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
%        </MeshHeading>
%        <MeshHeading>
%          <DescriptorName UI="D011597" MajorTopicYN="Y">Psychomotor Performance</DescriptorName>
%        </MeshHeading>
%      </MeshHeadingList>
%      <KeywordList Owner="NOTNLM">
%        <Keyword MajorTopicYN="Y">ALS</Keyword>
%        <Keyword MajorTopicYN="Y">FTD</Keyword>
%        <Keyword MajorTopicYN="Y">TDP-43</Keyword>
%        <Keyword MajorTopicYN="Y">cognitive deficit</Keyword>
%        <Keyword MajorTopicYN="Y">mitochondrial dysfunction</Keyword>
%        <Keyword MajorTopicYN="Y">motor dysfunction</Keyword>
%        <Keyword MajorTopicYN="Y">neurodegeneration</Keyword>
%        <Keyword MajorTopicYN="Y">transgenic mice</Keyword>
%      </KeywordList>
%    </MedlineCitation>
%    <PubmedData>
%      <History>
%        <PubMedPubDate PubStatus="received">
%          <Year>2016</Year>
%          <Month>06</Month>
%          <Day>17</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="revised">
%          <Year>2016</Year>
%          <Month>10</Month>
%          <Day>10</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="accepted">
%          <Year>2016</Year>
%          <Month>10</Month>
%          <Day>21</Day>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="entrez">
%          <Year>2017</Year>
%          <Month>1</Month>
%          <Day>28</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="pubmed">
%          <Year>2017</Year>
%          <Month>1</Month>
%          <Day>28</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%        <PubMedPubDate PubStatus="medline">
%          <Year>2017</Year>
%          <Month>6</Month>
%          <Day>7</Day>
%          <Hour>6</Hour>
%          <Minute>0</Minute>
%        </PubMedPubDate>
%      </History>
%      <PublicationStatus>ppublish</PublicationStatus>
%      <ArticleIdList>
%        <ArticleId IdType="pubmed">28129109</ArticleId>
%        <ArticleId IdType="pii">S1525-0016(16)45368-2</ArticleId>
%        <ArticleId IdType="doi">10.1016/j.ymthe.2016.10.013</ArticleId>
%        <ArticleId IdType="pmc">PMC5363201</ArticleId>
%      </ArticleIdList>
%    </PubmedData>
%  </PubmedArticle>
% END:Original PubMed XML


---------
Parse Error:
Expecting a ( or {{ to start a BibTeX reference:

    . Electronic address: xinglong.wang@case.edu.</Affiliation>  %            </Affi